HOME › Top Market Reports › Digital Pathology Market by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022

Digital Pathology Market by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: October 2017
Report Code: HIT 2608

The global digital pathology market is projected to be valued at USD 383.9 Million in 2016 and is expected to grow at a CAGR of 12.3% from 2017 to reach to USD 756.1 Million by 2022. Growth in the market is mainly driven by factors such as the growing applications of digital pathology in drug development and companion diagnostics, ease of consultation, increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, and increasing initiatives by governments and industry players. Base year considered for the report is 2016 and the forecast period is 2017–2022.

Objectives of the Study:

To define and measure the global market on the basis of product, type, end users, application, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
To identify the key micromarkets and their drivers within the global market
To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
To identify the market trends and opportunities for stakeholders in the market and provide details of the competitive landscape for major market players
To profile the key market players and comprehensively analyze their market shares and core competencies
To track and analyze competitive developments such as partnerships, agreements, and collaborations; expansions; acquisitions; and product launches

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global digital pathology market and estimate the size of other dependent submarkets. Various secondary sources such as associations like the U.S. Food and Drug Administration, Digital Pathology Association College of American Pathologists, American Society for Clinical Pathology, European Society of Pathology, Pathological Society of Great Britain and Ireland, International Academy of Pathology, International Association of Chinese Pathologists Centers for Medicare and Medicaid Services, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Digital Pathology Market

To know about the assumptions considered for the study, download the pdf brochure

The prominent players in the global digital pathology market are Leica Biosystems (Germany), Ventana Medical Systems (US), Hamamatsu Photonics (Japan), 3DHISTECH (Hungary), and Philips (Netherlands).

Target Audience:

Digital pathology equipment manufacturers
Suppliers and distributors of digital pathology equipment
Medical research institutes
Research institutes
Vendors/service providers

Scope of the Report:

The research report categorizes the digital pathology market into the following segments and subsegments:

By Product

Scanners
Software
Communication Systems
Storage Systems

By Type

Human Pathology
Veterinary Pathology

By End User

Pharmaceutical & Biotechnology Companies
Hospital and Reference Laboratories
Academic & Research Institutes

By Application

Teleconsultation
Disease Diagnosis
Drug Discovery
Training & Education

By Region

North America
- US
- Canada
Europe
- UK
- Germany
- Sweden
- Denmark
- Rest of Europe (RoE)
APAC
- China
- Japan
- India
- RoAPAC
Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covred
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
    2.2 Market Size Estimation Methodology
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Data Validation and Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 30)
    4.1 Digital Pathology Market: Overview
    4.2 European Market Share, By Application and Country (2017)
    4.3 Global Market, By Type vs Country 2017 vs 2022
    4.4 Geographic Snapshot of the Global Market

5 Market Overview (Page No. - 33)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Adoption of Digital Pathology to Enhance Lab Efficiency
                    5.2.1.2 Rising Prevalence of Cancer
                    5.2.1.3 Growing Applications of Digital Pathology in Drug Development and Companion Diagnostics
                    5.2.1.4 Ease of Consultation Enabled By Digital Pathology
                    5.2.1.5 Increasing Initiatives By Governments and Industry Players
           5.2.2 Restraints
                    5.2.2.1 High Cost of Digital Pathology Systems
           5.2.3 Opportunities
                    5.2.3.1 Overcoming the Shortage of Pathologists Through Digital Pathology
                    5.2.3.2 Introduction of Affordable Scanners for Private Pathology Practices
                    5.2.3.3 Personalized Medicine
                    5.2.3.4 Integration of Laboratory Information Systems (LIS) and Digital Pathology Systems
           5.2.4 Challenges
                    5.2.4.1 Lack of Standard Guidelines
    5.3 Regulatory Implications
           5.3.1 Health Insurance Portability and Accountability Act (HIPAA)
           5.3.2 Clinical Laboratory Improvement Amendments (CLIA)

6 Digital Pathology Market, By Product (Page No. - 41)
    6.1 Introduction
    6.2 Scanners
    6.3 Software
    6.4 Communication Systems
    6.5 Storage Systems

7 Digital Pathology Market, By Type (Page No. - 48)
    7.1 Introduction
    7.2 Human Pathology
    7.3 Veterinary Pathology

8 Digital Pathology Market, By Application (Page No. - 52)
    8.1 Introduction
    8.2 Teleconsultation
    8.3 Disease Diagnosis
    8.4 Drug Discovery
    8.5 Training and Education

9 Digital Pathology Market, By End User (Page No. - 58)
    9.1 Introduction
    9.2 Pharmaceutical & Biotechnology Companies
    9.3 Hospitals and Reference Laboratories
    9.4 Academic & Research Institutes

10 Global Digital Pathology Market, By Region (Page No. - 63)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 Favorable Reimbursement Scenario for Digital Pathology in the US
                        10.2.1.2 Rising Cancer Prevalence in the US
                        10.2.1.3 De Novo Application By the FDA
                        10.2.1.4 Conferences and Meetings in the US
             10.2.2 Canada
                        10.2.2.1 Growing Need for Quality Cancer Diagnosis in Canada
                        10.2.2.2 Implementation of Favorable Initiatives By Canadian Authorities
     10.3 Europe
             10.3.1 UK
                        10.3.1.1 Initiatives Adopted By Nhs England Promoting the Adoption of Digital Pathology in the UK
                        10.3.1.2 Technological Developments in the UK Market
                        10.3.1.3 Organization of Digital Pathology-Related Conferences in the UK
             10.3.2 Germany
                        10.3.2.1 Organization of Digital Pathology-Related Conferences in Germany
             10.3.3 Sweden
                        10.3.3.1 Increasing Government Initiatives and Deployment of Digital Pathology Solutions
             10.3.4 Denmark
                        10.3.4.1 High Cancer Prevalence to Boost Market Growth in Denmark
             10.3.5 Rest of Europe (RoE)
                        10.3.5.1 Integration & Deployment of Digital Pathology Solutions in France
                        10.3.5.2 Spain: Implementation of Digital Pathology-Related Projects
                        10.3.5.3 Digital Pathology Gaining Momentum in the Netherlands
     10.4 Asia Pacific
             10.4.1 China
                        10.4.1.1 Industry Initiatives to Boost Digital Pathology Market in China
                        10.4.1.2 Favorable Initiatives for the Adoption of Telepathology in China
             10.4.2 Japan
                        10.4.2.1 Initiatives By Industry Players for Cancer Diagnosis
             10.4.3 India
                        10.4.3.1 Increasing Incidence of Cancer in India
             10.4.4 Rest of Asia Pacific
                        10.4.4.1 Cancer Control Initiatives in Australia
     10.5 RoW
                        10.5.1.1 Potential for the Growth of Digital Pathology in Africa
                        10.5.1.2 Increasing Focus of Industry Players on the Middle East

11 Company Profiles (Page No. - 109)
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
     11.1 Leica Biosystems
     11.2 Ventana Medical Systems
     11.3 Hamamatsu Photonics
     11.4 3DHISTECH
     11.5 Koninklijke Philips
     11.6 Apollo Enterprise Imaging
     11.7 XIFIN
     11.8 Huron Digital Pathology
     11.9 Visiopharm
     11.10 Corista
     11.11 Indica Labs
     11.12 Objective Pathology Services

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 145)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details

List of Tables (85 Tables)

Table 1 Global Digital Pathology Market, By Product, 2015–2022 (USD Million)
Table 2 Digital Pathology Scanners Market, By Country/Region, 2015–2022 (USD Million)
Table 3 Digital Pathology Scanners Market, By Region, 2015–2022 (Units)
Table 4 Types of Digital Pathology Software
Table 5 Digital Pathology Software Market, By Country/Region, 2015–2022 (USD Million)
Table 6 Communication Systems Used in Digital Pathology
Table 7 Digital Pathology Communication Systems Market, By Country/Region, 2015–2022 (USD Million)
Table 8 Digital Pathology Storage Systems Market, By Country/Region, 2015–2022 (USD Million)
Table 9 Digital Pathology Market, By Type, 2015–2022 (USD Million)
Table 10 Human Pathology Market, By Country/Region, 2015–2022 (USD Million)
Table 11 Veterinary Pathology Market, By Country/ Region, 2015–2022 (USD Million)
Table 12 Global Digital Pathology Market Size, By Application, 2015–2022 (USD Million)
Table 13 Market for Teleconsultation, By Country/Region, 2015–2022 (USD Million)
Table 14 Market for Disease Diagnosis, By Country/Region, 2015–2022 (USD Million)
Table 15 Market for Drug Discovery, By Country/Region, 2015–2022 (USD Million)
Table 16 Market for Training and Education, By Country/Region, 2015–2022 (USD Million)
Table 17 Global Digital Pathology Market, By End User, 2015–2022 (USD Million)
Table 18 Market for Pharmaceutical & Biotechnology Companies, By Country, 2015–2022 (USD Million)
Table 19 Market for Hospital and Reference Laboratories, By Country, 2015–2022 (USD Million)
Table 20 Market for Academic and Research Institutes, By Country, 2015–2022 (USD Million)
Table 21 Market, By Region, 2015–2022 (USD Million)
Table 22 North America: Digital Pathology Market, By Country, 2015–2022 (USD Million)
Table 23 North America: Market, By Product, 2015–2022 (USD Million)
Table 24 North America: Market, By Type, 2015–2022 (USD Million)
Table 25 North America: Market, By Application, 2015–2022 (USD Million)
Table 26 North America: Market, By End User, 2015–2022 (USD Million)
Table 27 Conferences/Meetings/Courses/Workshops Held/To Be Held in the US
Table 28 US: Digital Pathology Market, By Product, 2015–2022 (USD Million)
Table 29 US: Market, By Type, 2015–2022 (USD Million)
Table 30 US: Market, By Application, 2015–2022 (USD Million)
Table 31 US: Market, By End User, 2015–2022 (USD Million)
Table 32 Canada: Digital Pathology Market, By Product, 2015–2022 (USD Million)
Table 33 Canada: Market, By Type, 2015–2022 (USD Million)
Table 34 Canada: Market, By Application, 2015–2022 (USD Million)
Table 35 Canada: Market, By End User, 2015–2022 (USD Million)
Table 36 Europe: Digital Pathology Market, By Country/Region, 2015–2022 (USD Million)
Table 37 Europe: Market, By Product, 2015–2022 (USD Million)
Table 38 Europe: Market, By Type, 2015–2022 (USD Million)
Table 39 Europe: Market, By Application, 2015–2022 (USD Million)
Table 40 Europe: Market, By End User, 2015–2022 (USD Million)
Table 41 UK: Digital Pathology Market, By Product, 2015–2022 (USD Million)
Table 42 UK: Market, By Type, 2015–2022 (USD Million)
Table 43 UK: Market, By Application, 2015–2022 (USD Million)
Table 44 UK: Market, By End User, 2015–2022 (USD Million)
Table 45 Germany: Digital Pathology Market, By Product, 2015–2022 (USD Million)
Table 46 Germany: Market, By Type, 2015–2022 (USD Million)
Table 47 Germany: Market, By Application, 2015–2022 (USD Million)
Table 48 Germany: Market, By End User, 2015–2022 (USD Million)
Table 49 Sweden: Digital Pathology Market, By Product, 2015–2022 (USD Million)
Table 50 Sweden: Market, By Type, 2015–2022 (USD Million)
Table 51 Sweden: Market, By Application, 2015–2022 (USD Million)
Table 52 Sweden: Market, By End User, 2015–2022 (USD Million)
Table 53 Denmark: Digital Pathology Market, By Product, 2015–2022 (USD Million)
Table 54 Denmark: Market, By Type, 2015–2022 (USD Million)
Table 55 Denmark: Market, By Application, 2015–2022 (USD Million)
Table 56 Denmark: Market, By End User, 2015–2022 (USD Million)
Table 57 RoE: Digital Pathology Market, By Product, 2015–2022 (USD Million)
Table 58 RoE: Market, By Type, 2015–2022 (USD Million)
Table 59 RoE: Market, By Application, 2015–2022 (USD Million)
Table 60 RoE: Market, By End User, 2015–2022 (USD Million)
Table 61 Asia Pacific: Digital Pathology Market, By Country, 2015-2022 (USD Million)
Table 62 Asia Pacific: Market, By Product, 2015-2022 (USD Million)
Table 63 Asia Pacific: Market, By Type, 2015-2022 (USD Million)
Table 64 Asia Pacific: Market, By Application, 2015-2022 (USD Million)
Table 65 Asia Pacific: Market, By End User, 2015-2022 (USD Million)
Table 66 China: Digital Pathology Market, By Product, 2015-2022 (USD Million)
Table 67 China: Market, By Type, 2015-2022 (USD Million)
Table 68 China: Market, By Application, 2015-2022 (USD Million)
Table 69 China: Market, By End User, 2015-2022 (USD Million)
Table 70 Japan: Digital Pathology Market, By Product, 2015-2022 (USD Million)
Table 71 Japan: Market, By Type, 2015-2022 (USD Million)
Table 72 Japan: Market, By Application, 2015-2022 (USD Million)
Table 73 Japan: Market, By End User, 2015-2022 (USD Million)
Table 74 India: Digital Pathology Market, By Product, 2015-2022 (USD Million)
Table 75 India: Market, By Type, 2015-2022 (USD Million)
Table 76 India: Market, By Application, 2015-2022 (USD Million)
Table 77 India: Market, By End User, 2015-2022 (USD Million)
Table 78 RoAPAC: Digital Pathology Market, By Product, 2015-2022 (USD Million)
Table 79 RoAPAC: Market, By Type, 2015-2022 (USD Million)
Table 80 RoAPAC: Market, By Application, 2015-2022 (USD Million)
Table 81 RoAPAC: Market, By End User, 2015-2022 (USD Million)
Table 82 RoW: Digital Pathology Market, By Product, 2015-2022 (USD Million)
Table 83 RoW: Market, By Type, 2015-2022 (USD Million)
Table 84 RoW: Market, By Application, 2015-2022 (USD Million)
Table 85 RoW: Market, By End User, 2015-2022 (USD Million)

List of Figures (33 Figures)

Figure 1 Global Digital Pathology Market Segmentation
Figure 2 Global Market: Research Methodology Steps
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Digital Pathology Market Analysis, By Product (2017)
Figure 7 Market Analysis, By Type, 2017 vs 2022
Figure 8 Market Analysis, By Application (2017)
Figure 9 Market Analysis, By End User, 2017 vs 2022
Figure 10 Asia Pacific Market to Witness the Highest Growth During the Forecast Period
Figure 11 Increasing Adoption of Digital Pathology is A Major Factor Driving the Growth of the Digital Pathology Market
Figure 12 Teleconsultation is Expected to Account for the Largest Share of the Market in 2017
Figure 13 Human Pathology to Continue to Dominate the Market in 2022
Figure 14 China to Register the Highest CAGR in the Forecast Period
Figure 15 Global Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Number of New Cancer Cases, By Country, 2012 vs 2020
Figure 17 Scanners Segment to Dominate the Digital Pathology Products Market During the Forecast Period
Figure 18 Global Market, By Type, 2017 vs 2022 (USD Million)
Figure 19 Teleconsultation Commands for Largest Market Size of the Digital Pathology Market in 2017, By Application
Figure 20 Global Market, By End User, 2017–2022
Figure 21 Global Market, By Region, 2017
Figure 22 North America: Market Snapshot
Figure 23 Increasing Prevalence of Cancer - A Major Factor Driving the North American Market
Figure 24 Europe: Market Snapshot
Figure 25 Europe: Number of Cancer Cases Reported, By Country
Figure 26 Cancer Prevalence in Denmark
Figure 27 Asia Pacific: Market Snapshot
Figure 28 Number of New Cancer Cases, By Type
Figure 29 RoW: Market Snapshot
Figure 30 Danaher Corporation: Company Snapshot
Figure 31 Roche Group: Company Snapshot
Figure 32 Hamamatsu Photonics: Company Snapshot
Figure 33 Koninklijke Philips: Company Snapshot

The global digital pathology market is projected to reach USD 756.1 Million by 2022 from USD 423.1 Million in 2017, at a CAGR of 12.3%. The key factors propelling the growth of this market include increasing initiatives by governments and industry players, ease of consultation, increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, and growing applications of digital pathology in drug development and companion diagnostics.

On the basis of product, the market is categorized into scanners, software, communication systems, and storage systems. The software segment is projected to witness the highest growth rate in the forecast period, due to the availability of user-friendly, analytical, and advanced functions for pathology diagnosis.

On the basis of type, the digital pathology market is segmented into human and veterinary pathology. The human pathology segment is expected to account for the largest share of the market in 2017. The increasing number of cancer research activities and growing collaborations between academic research institutes, universities, and pathology laboratories are driving the increased uptake of digital systems in human pathology.

On the basis of application, the market is segmented into disease diagnosis, teleconsultation, drug discovery, and training & education. The teleconsultation segment is estimated to account for the largest share of the global digital pathology market in 2017. Shortage of pathologists in developing countries and increasing need for quality and fast diagnosis have enhanced the utilization of teleconsultation applications across the globe.

On the basis of end user, the global digital pathology market has been segmented into pharmaceutical and biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the global market in 2017. Key factors driving the growth of this segment is the usage digital pathology for biobanking, biopharmaceutical studies, and molecular assays.

Digital Pathology Market

In 2017, North America is expected to account for the largest share of the digital pathology market, followed by Europe. The large share of the North American region can be attributed to factors such as increasing initiatives by industry players and governments in diagnostics and the rising prevalence of chronic diseases.

The prominent players in the global digital pathology market are Leica Biosystems (Germany), Ventana Medical Systems (US), Hamamatsu Photonics (Japan), 3DHISTECH (Hungary), Philips (Netherlands), Apollo Enterprise Imaging (US), XIFIN (US), Visiopharm (Denmark), Corista (US), Huron Digital Pathology (Canada), Objective Pathology Services (Canada), and Indica Labs (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services